Latest Chlamydia infection Stories

New UCSF/Kaiser Permanente study shows low risk following insertion of intrauterine devices with same-day screening The risk of developing pelvic inflammatory disease (PID) following insertion of an intrauterine device (IUD) is very low, whether or not women have been screened beforehand for gonorrhea and chlamydia, according to a joint study of nearly 60,000 women by researchers at the University of California, San Francisco (UCSF), and Kaiser Permanente Northern California Division of...

HAMILTON, N.J., Sept. 11, 2012 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C. (MDL), a CLIA-certified infectious disease laboratory which specializes in high complexity, state-of-the-art, automated DNA-based molecular analyses, announced that it is now offering an azithromycin resistance reflex assay for Chlamydia trachomatis. MDL is believed to be the first and only clinical laboratory to offer the antibiotic resistance for this sexually transmitted pathogen. Drug...

MADISON, N.J., May 23, 2012 /PRNewswire/ -- Many women are not screened for chlamydia and gonorrhea infection during their pregnancy, and follow-up testing is not always performed as medically recommended for those who test positive for chlamydia, according to a study published online in the American Journal of Obstetrics and Gynecology (AJOG). The findings, based on an analysis of laboratory tests of 1.3 million pregnant women, highlight gaps between medical guidelines...

SUNNYVALE, Calif., May 23, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that both Xpert® CT/NG and Xpert® CT have received CE marking, with shipments expected to begin immediately. Running on Cepheid's GeneXpert® System, the products are qualitative in vitro molecular diagnostic tests for the rapid detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). With results in less than 90 minutes, new opportunities for same-day patient...

A recent study posted in Nature Genetics explains that researchers have found that Chlamydia has been evolving differently than previously thought. The researchers used whole genome sequencing to find these results. Their findings show the exchange of DNA between different strains of the STD to form new strains is more common than expected. The researchers came about their findings while working with hospitals to improve their testing and detection of Chlamydia, particularly different...

Whole genome analysis of Chlamydia trachomatis highlights risks with current method of tracking In a study released today in Nature Genetics, researchers have found that Chlamydia has evolved more actively than was previously thought. Using whole genome sequencing the researchers show that the exchange of DNA between different strains of Chlamydia to form new strains is much more common than expected. The team highlights that current clinical testing methods do not capture the variation...

According to a report by the U.S. Centers for Disease Control and Prevention (CDC), half of Americans with chlamydia do not know they have it, and it is the top sexually transmitted disease (STD) reported to public health authorities. The U.S. Centers for Disease Control and Prevention's annual report on sexually transmitted diseases, which tracks cases of chlamydia, gonorrhea, and syphilis, has shown widespread disparities. The report said that the number two reported STD is gonorrhea,...

A breakthrough in the study of chlamydia genetics could open the way to new treatments and the development of a vaccine for this sexually transmitted disease. For decades research progress has been hampered because scientists have been prevented from fully understanding these bacteria as they have been unable to manipulate the genome of Chlamydia trachomatis. Now researchers in Southampton have made a significant breakthrough in accessing the chlamydial genome and believe it could pave...

NIH - developed vaccine based on live, attenuated Chlamydia bacteria An attenuated, or weakened, strain of Chlamydia trachomatis bacteria can be used as a vaccine to prevent or reduce the severity of trachoma, the world's leading cause of infectious blindness, suggest findings from a National Institutes of Health study in monkeys. "This work is an important milestone in the development of a trachoma vaccine," noted Anthony S. Fauci, M.D., director of the National Institute of Allergy...

A novel mechanism has been identified in which Chlamydia trachomatis tricks host cells into taking up the bacteria. Researchers from University of California San Francisco, led by Joanne Engel, report their findings in the Open Access journal PLoS Pathogens on October 6th. Dr. Engel and colleagues show that Chlamydia coat themselves with a growth factor made by the cells of the organism they are infecting. This disguise allows the bacteria to infect cells, much like a Trojan horse. Once...